Heritage Pharmaceuticals Inc., of Eatontown, N.J., agreed to pay more than $7 million in criminal penalties and civil damages for its part in a U.S. generics price fixing scheme. Under a deferred prosecution agreement with the U.S. Department of Justice (DoJ), Heritage admitted it conspired to fix prices, rig bids and allocate customers for generic versions of glyburide, a diabetes drug.